America’s fisheries are among the world’s richest in abundance and diversity. They provide scientific, aesthetic, recreational, commercial, subsistence, cultural, social, and economic benefits. FAC leads aquatic resource management for the Service and strives to invest its resources in the nation’s highest priority aquatic conservation and water-based recreational needs. Fish health is a critical component of healthy fisheries and core to the work of the Fish and Aquatic Conservation Program.
The Aquatic Animal Drug Approval Partnership (AADAP) program is part of the Fish and Aquatic Conservation fish health work. It is the only program in the United States singularly dedicated to obtaining U.S. Food and Drug Administration (FDA) approval of new medications needed for use in fish culture and fisheries management. Since the late 1990’s, AADAP has contributed to virtually every new fish medication approved by the FDA. Ultimately, the AADAP program allows fisheries professionals to more effectively and efficiently rear and manage a variety of fish species to meet production goals, stock healthy fish, and maintain a healthy environment.
AADAP is pleased to announce that for calendar year 2021, we will not be charging any INAD enrollment fees for the use of any of our INADs. Please see this letter detailing 2021 INAD Fee Suspension from the USFWS' Assistant Director of Fish and Aquatic Conservation, David Hoskins, for further information. INAD participants will still need to enroll with us, as per usual, for the INAD use to be considered legal, and so we can continue to collect the INAD use data. We sincerely thank you for your support for AADAP over the years, as this is what allows us to waive INAD fees for calendar year 2021. Please let us know if you have any questions!
Due to the ongoing COVID-19 pandemic and for the safety of everyone, the 27th Annual Aquaculture Drug Approval Coordination Workshop will be held VIRTUALLY, from July 27-29th, 2021. If you're interested in giving a presentation at the workshop, or if you have any specific aquaculture drug/drug approval process-related questions that you would like addressed during the workshop, please reach out to Julie Schroeter by May 28th, 2021. More details about the workshop, including registration information, will be available soon via the AADAP website and the AADAP Update. Please don't hesitate to reach out if you have any questions. Thank you.
Do you wish there was a webpage you could visit to answer any INAD questions that you may have? Can't remember how to add another fish species to your investigator account or even what is needed to get started with the INAD Program? Well, now you're in luck as AADAP has compiled the most common INAD questions that we've received and posted the answers to our new INAD U webpage!
Please visit INAD U for information that includes: how to add enrollment to your investigator account; how to change out an investigator or monitor; adding receipt of drug to the inventory page; and many more fascinating INAD topics. We hope to keep adding to this webpage with more how-to videos and additional INAD reference guides. Be sure to mark this webpage as a favorite as it is sure to be your go-to page whenever you have questions about the INAD Program.
Calling all Aquaculture America 2021 attendees! Are you interested in speaking in a special session at Aquaculture America 2021, to be held in San Antonio, Texas from August 11-14th, 2021. Please follow the link below to learn more about the National Aquaculture Association (NAA) special sessions that AADAP is co-hosting with the Aquatic Drug Approval Coalition (ADAC) and the Association of Fish and Wildlife Agencies-Drug Approval Working Group (AFWA-DAWG).